USD 172.78
(-1.63%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 970 Million USD | -0.55% |
2022 | 975.4 Million USD | 2886.44% |
2021 | 32.66 Million USD | -4.91% |
2020 | 34.34 Million USD | 67.66% |
2019 | 20.48 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 71 Thousand USD | -99.96% |
2015 | 185.14 Million USD | 47.0% |
2014 | 125.95 Million USD | 37385.12% |
2013 | 336 Thousand USD | -83.94% |
2012 | 2.09 Million USD | 1614.75% |
2011 | 122 Thousand USD | -29.07% |
2010 | 172 Thousand USD | -25.54% |
2009 | 231 Thousand USD | -62.86% |
2008 | 622 Thousand USD | -98.0% |
2007 | 31.04 Million USD | 47.52% |
2006 | 21.04 Million USD | -27.59% |
2005 | 29.06 Million USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
1999 | 2.4 Million USD | 60.0% |
1998 | 1.5 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 863.4 Million USD | -9.76% |
2024 Q1 | 956.8 Million USD | -1.36% |
2024 Q3 | 733.2 Million USD | -0.29% |
2023 Q1 | 897.5 Million USD | -12.76% |
2023 Q2 | 888.8 Million USD | -0.97% |
2023 Q4 | 970 Million USD | 6.58% |
2023 Q3 | 910.1 Million USD | 2.4% |
2023 FY | 970 Million USD | -0.55% |
2022 Q4 | 1.02 Billion USD | 4.58% |
2022 Q3 | 983.7 Million USD | 3.25% |
2022 Q1 | 38.9 Million USD | 19.11% |
2022 Q2 | 952.7 Million USD | 2349.04% |
2022 FY | 975.4 Million USD | 2886.44% |
2021 Q2 | 35.18 Million USD | -0.85% |
2021 Q3 | 33.61 Million USD | -4.46% |
2021 Q1 | 35.49 Million USD | 3.33% |
2021 Q4 | 32.66 Million USD | -2.85% |
2021 FY | 32.66 Million USD | -4.91% |
2020 FY | 34.34 Million USD | 67.66% |
2020 Q2 | 27.16 Million USD | -0.6% |
2020 Q3 | 28.55 Million USD | 5.14% |
2020 Q4 | 34.34 Million USD | 20.28% |
2020 Q1 | 27.32 Million USD | 33.37% |
2019 Q4 | 20.48 Million USD | -3.05% |
2019 FY | 20.48 Million USD | 0.0% |
2019 Q3 | 21.13 Million USD | 0.67% |
2019 Q2 | 20.99 Million USD | -2.01% |
2019 Q1 | 21.42 Million USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | -100.0% |
2017 FY | - USD | -100.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q3 | 152.5 Million USD | -12.89% |
2016 Q2 | 175.07 Million USD | -22.22% |
2016 FY | 71 Thousand USD | -99.96% |
2016 Q1 | 225.07 Million USD | 21.57% |
2016 Q4 | 71 Thousand USD | -99.95% |
2015 Q4 | 185.14 Million USD | -2.65% |
2015 Q1 | 125.19 Million USD | -0.6% |
2015 FY | 185.14 Million USD | 47.0% |
2015 Q2 | 177.68 Million USD | 41.93% |
2015 Q3 | 190.18 Million USD | 7.03% |
2014 Q3 | 125.23 Million USD | 66.44% |
2014 Q1 | 258 Thousand USD | -23.21% |
2014 FY | 125.95 Million USD | 37385.12% |
2014 Q2 | 75.24 Million USD | 29063.18% |
2014 Q4 | 125.95 Million USD | 0.57% |
2013 FY | 336 Thousand USD | -83.94% |
2013 Q3 | 355 Thousand USD | 4.41% |
2013 Q2 | 340 Thousand USD | -3.68% |
2013 Q4 | 336 Thousand USD | -5.35% |
2013 Q1 | 353 Thousand USD | -83.13% |
2012 Q1 | 110 Thousand USD | -9.84% |
2012 Q2 | 97 Thousand USD | -11.82% |
2012 Q3 | 129 Thousand USD | 32.99% |
2012 Q4 | 2.09 Million USD | 1521.71% |
2012 FY | 2.09 Million USD | 1614.75% |
2011 FY | 122 Thousand USD | -29.07% |
2011 Q4 | 122 Thousand USD | -9.63% |
2011 Q3 | 135 Thousand USD | -7.53% |
2011 Q2 | 146 Thousand USD | -6.41% |
2011 Q1 | 156 Thousand USD | -9.3% |
2010 Q1 | 216 Thousand USD | -6.49% |
2010 FY | 172 Thousand USD | -25.54% |
2010 Q2 | 203 Thousand USD | -6.02% |
2010 Q3 | 188 Thousand USD | -7.39% |
2010 Q4 | 172 Thousand USD | -8.51% |
2009 Q4 | 231 Thousand USD | -44.07% |
2009 FY | 231 Thousand USD | -62.86% |
2009 Q3 | 413 Thousand USD | -2.82% |
2009 Q1 | 543 Thousand USD | -12.7% |
2009 Q2 | 425 Thousand USD | -21.73% |
2008 Q4 | 622 Thousand USD | -17.07% |
2008 Q3 | 750 Thousand USD | -19.53% |
2008 Q2 | 932 Thousand USD | -34.92% |
2008 Q1 | 1.43 Million USD | -95.39% |
2008 FY | 622 Thousand USD | -98.0% |
2007 Q1 | 31.73 Million USD | 50.82% |
2007 FY | 31.04 Million USD | 47.52% |
2007 Q2 | 37.05 Million USD | 16.75% |
2007 Q3 | 34.07 Million USD | -8.03% |
2007 Q4 | 31.04 Million USD | -8.91% |
2006 FY | 21.04 Million USD | -27.59% |
2006 Q4 | 21.04 Million USD | 0.0% |
2005 Q4 | 29.06 Million USD | 0.0% |
2005 FY | 29.06 Million USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 FY | - USD | 0.0% |
1999 FY | 2.4 Million USD | 60.0% |
1998 FY | 1.5 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Phreesia, Inc. | 11.98 Million USD | -7994.801% |
Accuray Incorporated | 172.15 Million USD | -463.442% |
Align Technology, Inc. | 96.96 Million USD | -900.33% |
Elevance Health Inc. | 25.12 Billion USD | 96.139% |
AxoGen, Inc. | 69.29 Million USD | -1299.873% |
Boston Scientific Corporation | 9.09 Billion USD | 89.337% |
CVS Health Corporation | 79.38 Billion USD | 98.778% |
Cardinal Health, Inc. | 5.6 Billion USD | 82.706% |
Centene Corporation | 17.69 Billion USD | 94.519% |
DaVita Inc. | 11.11 Billion USD | 91.274% |
HCA Healthcare, Inc. | 41.85 Billion USD | 97.683% |
Hologic, Inc. | 2.53 Billion USD | 61.73% |
Humana Inc. | 10.21 Billion USD | 90.502% |
IDEXX Laboratories, Inc. | 947.88 Million USD | -2.334% |
Laboratory Corporation of America Holdings | 5.95 Billion USD | 83.709% |
McKesson Corporation | 5.47 Billion USD | 82.273% |
Patterson Companies, Inc. | 762.94 Million USD | -27.14% |
Quest Diagnostics Incorporated | 5.36 Billion USD | 81.933% |
ResMed Inc. | 873.93 Million USD | -10.992% |
Henry Schein, Inc. | 2.74 Billion USD | 64.611% |
Teladoc Health, Inc. | 1.59 Billion USD | 39.081% |
Universal Health Services, Inc. | 5.36 Billion USD | 81.925% |
Veeva Systems Inc. | 55.77 Million USD | -1639.13% |
Baxter International Inc. | 14.36 Billion USD | 93.247% |
Becton, Dickinson and Company | 15.87 Billion USD | 93.891% |
Intuitive Surgical, Inc. | 89.8 Million USD | -980.178% |
Danaher Corporation | 19.35 Billion USD | 94.989% |
Stryker Corporation | 12.99 Billion USD | 92.536% |
Medtronic plc | 24.96 Billion USD | 96.114% |